Migraine (Q79890177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Migraine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Stephen D Silberstein

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

9406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

381-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migraine diagnosis and treatment: results from the American Migraine Study II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

A gene for familial hemiplegic migraine maps to chromosome 19

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Perfusion weighted imaging during migraine: spontaneous visual aura and headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Perfusion‐weighted imaging defects during spontaneous migrainous aura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Neurobiology of migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Functional MRI-BOLD of visually triggered headache in patients with migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Recent advances in functional neuroimaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Magnetoencephalographic studies of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

The occipital cortex is hyperexcitable in migraine: experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Interictal cortical excitability in migraine: a study using transcranial magnetic stimulation of motor and visual cortices.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Sensitization of meningeal sensory neurons and the origin of headaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

SUMATRIPTAN: a receptor-targeted treatment for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Pattern of intracranial and extracranial projections of trigeminal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Brain stem activation in spontaneous human migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Brainstem activation specific to migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Differential Distribution of 5Ht1D-and 5HT1B-Immunoreactivity within the Human Trigemino-Cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migraine aura and prodrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Premonitory symptoms in migraine: an electronic diary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

A nosographic analysis of the migraine aura in a general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migraine Symptoms: Results of a Survey of Self‐Reported Migraineurs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Modular headache theory.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migraine without headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migrainous visual accompaniments are not rare in late life: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Late-life migraine accompaniments--further experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Butalbital in the treatment of headache: history, pharmacology, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

1 reference

7 January 2021

Migraine and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

A controlled study of dihydroergotamine in the treatment of acute migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Cardiac risk factors and the use of triptans: a survey study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Subcutaneous sumatriptan during the migraine aura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Ergotamine and dihydroergotamine: history, pharmacology, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Ergotamine in the acute treatment of migraine: a review and European consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Repetitive intravenous DHE in the treatment of refractory headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Migraine: preventive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Double-blind trial of fluoxetine: chronic daily headache and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Divalproex sodium in headache: literature review and clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Efficacy of gabapentin in migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

1 reference

7 January 2021

Feverfew as a preventive treatment for migraine: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

From CSD to headache: a long and winding road

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915440-8

7 January 2021

10.1016/S0140-6736(04)15440-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15070571%20AND%20SRC:MED&resulttype=core&format=json